It has been reported that LPS could stimulate the TLR4-NF-κB signaling pathway to induce the release of TNF-α, IL-1β, and IL-6, which are inflammatory cytokines in inflammatory bowel disease (Gerges et al., 2020). This evidence concerns the gene IL6 and inflammatory bowel disease.